Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
•
Melanoma/Skin Cancer
•
Medical Oncology
What is your approach to treating inoperable mucosal melanoma of the head and neck region?
What is the preferred dose, fractionation, and role of concurrent chemo?
Answer from: Radiation Oncologist at Academic Institution
It is often nasal cavity/paranasal sinuses, so 1.2 Gy BID to 74.4 Gy and electively treat the neck. Otherwise 70 Gy/35 fx/30 treatment days SIB.
Comments
Radiation Oncologist at The Toledo Clinic
Do you treat only the ipsilateral neck?
Radiation Oncologist at University of Florida
I would treat the ipsilateral neck electively.
Radiation Oncologist at The Toledo Clinic
Thank you.
Radiation Oncologist at Providence St. Mary Medical Center
Role for immunotherapy? Neoadj or Adj?
10987
10991
10993
14435
Sign In
or
Register
to read more
675
Related Questions
Is there a scenario in which you would consider observation for T4a SCC involving the mandible?
What is your recommendation for patients who are on weight loss medications like GLP-1-based therapies while receiving chemoradiation for head and neck cancer?
How, if at all, are you modifying your practice and clinical workflow for patients receiving checkpoint inhibitors with data showing improved outcomes for patients receiving infusions earlier in the day?
How would you apply the results of CheckMate 204 in an asymptomatic patient with 10-20 metastatic brain lesions on dual immunotherapy for melanoma?
Would you consider adjuvant immunotherapy for a patient with high-risk Merkel cell carcinoma following definitive surgical resection and adjuvant radiation therapy?
In what situations would you recommend adjuvant radiation therapy for patients with locally advanced and/or recurrent basal cell carcinoma that receive vismodegib followed by surgery?
Would you recommend large-field radiation therapy to treat SCC of the skin with field cancerization (e.g., entire forearm, scalp) in elderly patients with CLL/immune compromise who have had mixed responses to cemiplimab?
How do you approach cisplatin dosing for locally advanced head and neck SCC in HPV-positive and HPV-negative patients?
How would the updated results of ECOG 3311 influence your adjuvant RT recommendations for HPV+ OPSCC?
If adjuvant radiation is offered to an elderly patient with H&N SCC s/p Mohs surgery who is planned for multi-stage reconstruction of the defect with plastic surgery, when should adjuvant radiation be started?
Do you treat only the ipsilateral neck?
I would treat the ipsilateral neck electively.
Thank you.
Role for immunotherapy? Neoadj or Adj?